Page last updated: 2024-09-02

dihydrokainate and bay 11-7082

dihydrokainate has been researched along with bay 11-7082 in 1 studies

Compound Research Comparison

Studies
(dihydrokainate)
Trials
(dihydrokainate)
Recent Studies (post-2010)
(dihydrokainate)
Studies
(bay 11-7082)
Trials
(bay 11-7082)
Recent Studies (post-2010) (bay 11-7082)
1800465701383

Protein Interaction Comparison

ProteinTaxonomydihydrokainate (IC50)bay 11-7082 (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.82
Nuclear factor NF-kappa-B p105 subunitHomo sapiens (human)2
Nuclear factor NF-kappa-B p100 subunit Homo sapiens (human)2
Transcription factor p65Homo sapiens (human)2.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gong, SJ; Hu, YY; Li, WB; Sun, YW; Xian, XH; Zhang, JG; Zhang, LY; Zhang, M1

Other Studies

1 other study(ies) available for dihydrokainate and bay 11-7082

ArticleYear
The p38 MAPK/NF-κB pathway mediates GLT-1 up-regulation during cerebral ischemic preconditioning-induced brain ischemic tolerance in rats.
    Brain research bulletin, 2021, Volume: 175

    Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Excitatory Amino Acid Transporter 2; Imidazoles; Ischemic Preconditioning; Kainic Acid; Male; MAP Kinase Signaling System; Neuroprotection; NF-kappa B; NF-kappa B p50 Subunit; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Wistar; Sulfones; Transcription Factor RelA

2021